Polyendocrinopathies, Autoimmune
"Polyendocrinopathies, Autoimmune" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Autoimmune diseases affecting multiple endocrine organs. Type I is characterized by childhood onset and chronic mucocutaneous candidiasis (CANDIDIASIS, CHRONIC MUCOCUTANEOUS), while type II exhibits any combination of adrenal insufficiency (ADDISON'S DISEASE), lymphocytic thyroiditis (THYROIDITIS, AUTOIMMUNE;), HYPOPARATHYROIDISM; and gonadal failure. In both types organ-specific ANTIBODIES against a variety of ENDOCRINE GLANDS have been detected. The type II syndrome differs from type I in that it is associated with HLA-A1 and B8 haplotypes, onset is usually in adulthood, and candidiasis is not present.
Descriptor ID |
D016884
|
MeSH Number(s) |
C19.787 C20.111.750
|
Concept/Terms |
Polyglandular Type III Autoimmune Syndrome- Polyglandular Type III Autoimmune Syndrome
- Polyglandular Autoimmune Syndrome, Type 3
- Autoimmune Syndrome Type III, Polyglandular
- Autoimmune Polyglandular Syndrome Type III
- Autoimmune Polyglandular Syndrome, Type 3
Polyglandular Type I Autoimmune Syndrome- Polyglandular Type I Autoimmune Syndrome
- APECED
- APS Type 1
- Autoimmune Polyendocrinopathy Syndrome Type 1
- Autoimmune Polyendocrinopathy with Candidiasis and Ectodermal Dystrophy
- Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy
- Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy
- Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy, Autoimmune
- Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy
- Autoimmune Polyglandular Syndrome Type I
- Autoimmune Polyglandular Syndrome, Type 1
- Autoimmune Polyglandular Syndrome, Type I
- Autoimmune Syndrome Type I, Polyglandular
- Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy, Autoimmune
- Polyendocrinopathy Candidiasis Ectodermal Dystrophy, Autoimmune
- Polyglandular Autoimmune Syndrome, Type 1
- Polyglandular Autoimmune Syndrome, Type I
- AIRE Deficiency
- AIRE Deficiencies
- Deficiency, AIRE
Polyglandular Type II Autoimmune Syndrome- Polyglandular Type II Autoimmune Syndrome
- Autoimmune Polyendocrine Syndrome, Type II
- Autoimmune Polyglandular Syndrome Type II
- Autoimmune Syndrome Type II, Polyglandular
- Diabetes Mellitus, Addison Disease, Myxedema
- Schmidt's Syndrome
- Syndrome, Schmidt's
- Multiple Endocrine Deficiency Syndrome, Type 2
- Polyendocrine Autoimmune Syndrome, Type II
- Polyglandular Autoimmune Syndrome, Type 2
- Polyglandular Deficiency Syndrome, Type 2
- Schmidt Syndrome
- Syndrome, Schmidt
- Autoimmune Polyendocrine Syndrome, Type 2
- Diabetes Mellitus, Addison's Disease, Myxedema
|
Below are MeSH descriptors whose meaning is more general than "Polyendocrinopathies, Autoimmune".
Below are MeSH descriptors whose meaning is more specific than "Polyendocrinopathies, Autoimmune".
This graph shows the total number of publications written about "Polyendocrinopathies, Autoimmune" by people in this website by year, and whether "Polyendocrinopathies, Autoimmune" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 1 | 0 | 1 |
2012 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polyendocrinopathies, Autoimmune" by people in Profiles.
-
Break TJ, Oikonomou V, Dutzan N, Desai JV, Swidergall M, Freiwald T, Chauss D, Harrison OJ, Alejo J, Williams DW, Pittaluga S, Lee CR, Bouladoux N, Swamydas M, Hoffman KW, Greenwell-Wild T, Bruno VM, Rosen LB, Lwin W, Renteria A, Pontejo SM, Shannon JP, Myles IA, Olbrich P, Ferr? EMN, Schmitt M, Martin D, Barber DL, Solis NV, Notarangelo LD, Serreze DV, Matsumoto M, Hickman HD, Murphy PM, Anderson MS, Lim JK, Holland SM, Filler SG, Afzali B, Belkaid Y, Moutsopoulos NM, Lionakis MS. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021 01 15; 371(6526).
-
Winer KK, Kelly A, Johns A, Zhang B, Dowdy K, Kim L, Reynolds JC, Albert PS, Cutler GB. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism. J Pediatr. 2018 12; 203:391-399.e1.
-
Hansen CH, Yurkovetskiy LA, Chervonsky AV. Cutting Edge: Commensal Microbiota Has Disparate Effects on Manifestations of Polyglandular Autoimmune Inflammation. J Immunol. 2016 08 01; 197(3):701-5.
-
Price JV, Haddon DJ, Kemmer D, Delepine G, Mandelbaum G, Jarrell JA, Gupta R, Balboni I, Chakravarty EF, Sokolove J, Shum AK, Anderson MS, Cheng MH, Robinson WH, Browne SK, Holland SM, Baechler EC, Utz PJ. Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus. J Clin Invest. 2013 Dec; 123(12):5135-45.
-
Zella GC, Israel EJ. Chronic diarrhea in children. Pediatr Rev. 2012 May; 33(5):207-17; quiz 217-8.
-
Quintos JB, Grover M, Boney CM, Salas M. Autoimmune polyglandular syndrome Type 3 and growth hormone deficiency. Pediatr Diabetes. 2010 Sep; 11(6):438-42.